|
|
| Cerebrospinal fluid markers in multiple sclerosis: an overview |
1 |
| AR Massaro & P Tonali
|
|
Abstract
Full Article (PDF)
|
|
| Protein markers of brain damage |
5 |
| EJ Thompson & AJE Green
|
|
Abstract
Full Article (PDF)
|
|
| Multiple Sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls |
7 |
| S Sivieri,
AM Ferrarini & P Gallo
|
|
Abstract
Full Article (PDF)
|
|
| The cytokine storm in multiple sclerosis |
12 |
| Hans Link
|
|
Abstract
Full Article (PDF)
|
|
| Myelin basic protein in cerebrospinal fluid and other body fluids |
16 |
| John N Whitaker
|
|
Abstract
Full Article (PDF)
|
|
| Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI |
22 |
| Jette L Frederiksen & Christian JM Sindic
|
|
Abstract
Full Article (PDF)
|
|
| Cerebrospinal fluid and serum nitric oxide metabolites in patients with multiple sclerosis |
27 |
| G Giovannoni
|
|
Abstract
Full Article (PDF)
|
|
| Identification of peptides binding to IgG in the CSF of Multiple Sclerosis patients |
31 |
| I Cortese,
S Capone,
R Tafi,
LME Grimaldi,
A Nicosia & R Cortese
|
|
Abstract
Full Article (PDF)
|
|
| Abnormalities of biogenic amines affecting the metabolism of serotonin and catecholamines |
37 |
| Karel JB Lamers & Ron A Wevers
|
|
Abstract
Full Article (PDF)
|
|
| Soluble Intercellular Adhesion Molecule-1 (sICAM-1) in serum and cerebrospinal fluid of demyelinating diseases of the central and peripheral nervous system |
39 |
| M Trojano,
C Avolio,
M Ruggieri,
F De Robertis,
F Giuliani,
D Paolicelli & P Livrea
|
|
Abstract
Full Article (PDF)
|
|